https://lipidbank.jp/mediawiki/index.php?action=history&feed=atom&title=LBF20207PG31
LBF20207PG31 - Revision history
2026-04-30T17:21:48Z
Revision history for this page on the wiki
MediaWiki 1.43.0
https://lipidbank.jp/mediawiki/index.php?title=LBF20207PG31&diff=52634&oldid=prev
Editor at 08:32, 21 October 2010
2010-10-21T08:32:18Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 17:32, 21 October 2010</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td>
<td colspan="2" class="diff-lineno">Line 6:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1719</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1719</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010036</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010036</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=(9alpha,11beta,15S) -Trihydroxy-prosta- (5-<del style="font-weight: bold; text-decoration: none;">cis,</del>13<del style="font-weight: bold; text-decoration: none;">-trans</del>) -dien-1-oic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=(9alpha,11beta,15S) -Trihydroxy-prosta- (<ins style="font-weight: bold; text-decoration: none;">cis-</ins>5<ins style="font-weight: bold; text-decoration: none;">,trans</ins>-13) -dien-1-oic acid</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&11beta- Prostaglandin F_2 alpha&&(9alpha,11beta,15S) -Trihydroxy-prosta- (5Z,13E) -dien-1-oic acid</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&11beta- Prostaglandin F_2 alpha&&(9alpha,11beta,15S) -Trihydroxy-prosta- (5Z,13E) -dien-1-oic acid</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=11 beta -PGF2 alpha is the primary plasma metabolite of PGD2 in vivo.[[Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030|{{RelationTable/GetFirstAuthor|Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=11 beta -PGF2 alpha is the primary plasma metabolite of PGD2 in vivo.[[Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030|{{RelationTable/GetFirstAuthor|Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030}}]]</div></td></tr>
<!-- diff cache key wikidb:diff:1.41:old-52633:rev-52634:php=table -->
</table>
Editor
https://lipidbank.jp/mediawiki/index.php?title=LBF20207PG31&diff=52633&oldid=prev
Editor at 01:07, 3 June 2010
2010-06-03T01:07:16Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 10:07, 3 June 2010</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7">Line 7:</td>
<td colspan="2" class="diff-lineno">Line 7:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010036</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010036</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=(9alpha,11beta,15S) -Trihydroxy-prosta- (5-cis,13-trans) -dien-1-oic acid</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=(9alpha,11beta,15S) -Trihydroxy-prosta- (5-cis,13-trans) -dien-1-oic acid</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&11beta- Prostaglandin <del style="font-weight: bold; text-decoration: none;">F_2alpha</del>&&(9alpha,11beta,15S) -Trihydroxy-prosta- (5Z,13E) -dien-1-oic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&11beta- Prostaglandin <ins style="font-weight: bold; text-decoration: none;">F_2 alpha</ins>&&(9alpha,11beta,15S) -Trihydroxy-prosta- (5Z,13E) -dien-1-oic acid</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=11 beta -PGF2 alpha is the primary plasma metabolite of PGD2 in vivo.[[Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030|{{RelationTable/GetFirstAuthor|Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=11 beta -PGF2 alpha is the primary plasma metabolite of PGD2 in vivo.[[Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030|{{RelationTable/GetFirstAuthor|Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030}}]]</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr>
<!-- diff cache key wikidb:diff:1.41:old-52632:rev-52633:php=table -->
</table>
Editor
https://lipidbank.jp/mediawiki/index.php?title=LBF20207PG31&diff=52632&oldid=prev
Editor at 04:01, 27 May 2010
2010-05-27T04:01:01Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 13:01, 27 May 2010</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td>
<td colspan="2" class="diff-lineno">Line 6:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1719</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1719</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010036</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010036</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,11beta,15S-Trihydroxy-prosta-<del style="font-weight: bold; text-decoration: none;">5Z</del>,<del style="font-weight: bold; text-decoration: none;">13E</del>-dien-1-oic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=<ins style="font-weight: bold; text-decoration: none;">(</ins>9alpha,11beta,15S<ins style="font-weight: bold; text-decoration: none;">) </ins>-Trihydroxy-prosta- <ins style="font-weight: bold; text-decoration: none;">(5-cis</ins>,<ins style="font-weight: bold; text-decoration: none;">13-trans) </ins>-dien-1-oic acid</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&11beta- Prostaglandin F_2alpha&&</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&11beta- Prostaglandin F_2alpha&&<ins style="font-weight: bold; text-decoration: none;">(9alpha,11beta,15S) -Trihydroxy-prosta- (5Z,13E) -dien-1-oic acid</ins></div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=11 beta -PGF2 alpha is the primary plasma metabolite of PGD2 in vivo.[[Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030|{{RelationTable/GetFirstAuthor|Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=11 beta -PGF2 alpha is the primary plasma metabolite of PGD2 in vivo.[[Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030|{{RelationTable/GetFirstAuthor|Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030}}]]</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr>
<!-- diff cache key wikidb:diff:1.41:old-52631:rev-52632:php=table -->
</table>
Editor
https://lipidbank.jp/mediawiki/index.php?title=LBF20207PG31&diff=52631&oldid=prev
Editor at 04:47, 23 April 2010
2010-04-23T04:47:52Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 13:47, 23 April 2010</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td>
<td colspan="2" class="diff-lineno">Line 6:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1719</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1719</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010036</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010036</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,11beta,15S-<del style="font-weight: bold; text-decoration: none;">trihydroxy</del>-prosta-5Z,13E-dien-1-oic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,11beta,15S-<ins style="font-weight: bold; text-decoration: none;">Trihydroxy</ins>-prosta-5Z,13E-dien-1-oic acid</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&11beta- Prostaglandin F_2alpha&&</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&11beta- Prostaglandin F_2alpha&&</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=11 beta -PGF2 alpha is the primary plasma metabolite of PGD2 in vivo.[[Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030|{{RelationTable/GetFirstAuthor|Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=11 beta -PGF2 alpha is the primary plasma metabolite of PGD2 in vivo.[[Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030|{{RelationTable/GetFirstAuthor|Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030}}]]</div></td></tr>
<!-- diff cache key wikidb:diff:1.41:old-52630:rev-52631:php=table -->
</table>
Editor
https://lipidbank.jp/mediawiki/index.php?title=LBF20207PG31&diff=52630&oldid=prev
Editor at 04:46, 23 April 2010
2010-04-23T04:46:36Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 13:46, 23 April 2010</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7">Line 7:</td>
<td colspan="2" class="diff-lineno">Line 7:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010036</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010036</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,11beta,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,11beta,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&11beta-Prostaglandin F_2alpha&&</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&11beta- Prostaglandin F_2alpha&&</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=11 beta -PGF2 alpha is the primary plasma metabolite of PGD2 in vivo.[[Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030|{{RelationTable/GetFirstAuthor|Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=11 beta -PGF2 alpha is the primary plasma metabolite of PGD2 in vivo.[[Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030|{{RelationTable/GetFirstAuthor|Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030}}]]</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr>
<!-- diff cache key wikidb:diff:1.41:old-52629:rev-52630:php=table -->
</table>
Editor
https://lipidbank.jp/mediawiki/index.php?title=LBF20207PG31&diff=52629&oldid=prev
Editor at 21:00, 14 April 2010
2010-04-14T21:00:00Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 06:00, 15 April 2010</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7">Line 7:</td>
<td colspan="2" class="diff-lineno">Line 7:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010036</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010036</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,11beta,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,11beta,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&11beta-Prostaglandin F_2alpha<del style="font-weight: bold; text-decoration: none;">&&9alpha,11beta,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid</del>&&</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&11beta-Prostaglandin F_2alpha&&</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=11 beta -PGF2 alpha is the primary plasma metabolite of PGD2 in vivo.[[Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030|{{RelationTable/GetFirstAuthor|Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030}}]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=11 beta -PGF2 alpha is the primary plasma metabolite of PGD2 in vivo.[[Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030|{{RelationTable/GetFirstAuthor|Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030}}]]</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr>
<!-- diff cache key wikidb:diff:1.41:old-52628:rev-52629:php=table -->
</table>
Editor
https://lipidbank.jp/mediawiki/index.php?title=LBF20207PG31&diff=52628&oldid=prev
Editor at 10:00, 25 February 2010
2010-02-25T10:00:10Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<tr class="diff-title" lang="en">
<td colspan="1" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="1" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 19:00, 25 February 2010</td>
</tr><tr><td colspan="2" class="diff-notice" lang="en"><div class="mw-diff-empty">(No difference)</div>
</td></tr></table>
Editor
https://lipidbank.jp/mediawiki/index.php?title=LBF20207PG31&diff=52627&oldid=prev
Editor at 14:00, 19 February 2010
2010-02-19T14:00:10Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 23:00, 19 February 2010</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l8">Line 8:</td>
<td colspan="2" class="diff-lineno">Line 8:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,11beta,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,11beta,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&11beta-Prostaglandin F_2alpha&&9alpha,11beta,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid&&</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&11beta-Prostaglandin F_2alpha&&9alpha,11beta,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid&&</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Source=<del style="font-weight: bold; text-decoration: none;">11beta</del>-<del style="font-weight: bold; text-decoration: none;">PGF2alpha </del>is the primary plasma metabolite of PGD2 in vivo.[[Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030|{{RelationTable/GetFirstAuthor|Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030}}]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Source=<ins style="font-weight: bold; text-decoration: none;">11 beta </ins>-<ins style="font-weight: bold; text-decoration: none;">PGF2 alpha </ins>is the primary plasma metabolite of PGD2 in vivo.[[Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030|{{RelationTable/GetFirstAuthor|Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030}}]]</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td></tr>
<!-- diff cache key wikidb:diff:1.41:old-52626:rev-52627:php=table -->
</table>
Editor
https://lipidbank.jp/mediawiki/index.php?title=LBF20207PG31&diff=52626&oldid=prev
Editor at 14:00, 19 February 2010
2010-02-19T14:00:00Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 23:00, 19 February 2010</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l8">Line 8:</td>
<td colspan="2" class="diff-lineno">Line 8:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,11beta,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9alpha,11beta,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&11beta-Prostaglandin F_2alpha&&9alpha,11beta,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid&&</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&&11beta-Prostaglandin F_2alpha&&9alpha,11beta,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid&&</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Source=<del style="font-weight: bold; text-decoration: none;">11<FONT FACE="Symbol">b</FONT></del>-<del style="font-weight: bold; text-decoration: none;">PGF2<FONT FACE="Symbol">a</FONT> </del>is the primary plasma metabolite of PGD2 in vivo.[[Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030|{{RelationTable/GetFirstAuthor|Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030}}]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Source=<ins style="font-weight: bold; text-decoration: none;">11beta</ins>-<ins style="font-weight: bold; text-decoration: none;">PGF2alpha </ins>is the primary plasma metabolite of PGD2 in vivo.[[Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030|{{RelationTable/GetFirstAuthor|Reference:Liston_TE:Roberts_LJ:2nd:,Proc. Natl. Acad. Sci. U. S. A.,1985,82,6030}}]]</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td></tr>
<!-- diff cache key wikidb:diff:1.41:old-52625:rev-52626:php=table -->
</table>
Editor
https://lipidbank.jp/mediawiki/index.php?title=LBF20207PG31&diff=52625&oldid=prev
Editor at 21:00, 6 January 2010
2010-01-06T21:00:00Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 06:00, 7 January 2010</td>
</tr><tr><td colspan="4" class="diff-notice" lang="en"><div class="mw-diff-empty">(No difference)</div>
</td></tr>
<!-- diff cache key wikidb:diff:1.41:old-52624:rev-52625 -->
</table>
Editor